This paper investigates the clinical value of adjunctive procalcitonin (PCT) measurement in the early diagnosis of bacteremia and bacterial pneumonia among critically ill adult patients admitted to the intensive care unit. Using a PICO framework, the paper reviews available evidence on how serum PCT levels correlate with systemic bacterial infection, differentiating between gram-negative and gram-positive bacterial strains. It evaluates PCT against conventional markers such as C-reactive protein and white blood cell count, examines alternative preventive and diagnostic strategies, and discusses the consequences of delayed diagnosis. The paper concludes that PCT measurement, used alongside other diagnostic tools, supports earlier empiric antibiotic treatment and may improve patient survival outcomes in ICU settings.
The paper demonstrates systematic evidence synthesis within a clinical PICO structure. Rather than presenting a single study, it aggregates findings from over a dozen peer-reviewed sources and reconciles contradictions — for example, explaining why some studies show higher PCT in gram-negative bacteremia while others show the opposite in specific conditions such as infective endocarditis or S. pneumoniae. This comparative reasoning technique is central to evidence-based medicine writing.
The paper opens by contextualizing the problem of opportunistic infections in ICU patients, then defines key terms before formally stating the PICO question. Subsequent sections move from clinical relevance to a review of PCT effectiveness, a detailed analytical discussion of elevation patterns by bacterial strain, alternative solutions, and clinical outcomes, before arriving at a conclusion that directly answers the PICO question. This progression from problem definition to evidence review to actionable conclusion reflects a standard evidence-based practice report structure.
The main objective of providing treatment to patients is to relieve symptoms while decreasing the progression of disease and reducing mortality and morbidity. However, in some cases this objective is not fully achieved, particularly for patients admitted to the ICU with serious or terminal illness. For example, when elderly patients are admitted to the ICU, their immunity is extremely low, creating ideal conditions for opportunistic infections to worsen their prognosis. Many infections are specifically associated with patients admitted to hospital settings. Pseudomonas aeruginosa is a well-documented microorganism that causes bacterial pneumonia and bacteremia in terminally ill patients receiving hospital-based treatment.
Since most ICU patients are not conscious or are in a comatose state, it becomes very difficult for doctors and nursing staff to make an early diagnosis of these infections. By the time clinicians and paramedics identify the deteriorating condition caused by opportunistic pathogens, it is usually too late to save the patient's life.
Before beginning the discussion based on the PICO question, it is useful to define some key terms that appear frequently throughout this paper.
The term "adult patients" is used in two contexts. First, adult patients are most prone to infections because they often have a depressed immune system. Second, adult patients are those most frequently admitted to the ICU with a terminal or very serious illness.
The term "critically ill" refers to patients admitted to the ICU with a potentially fatal disease or those in the terminal stages of any illness.
"Bacteremia" refers to the presence of bacteria of any strain in the circulating bloodstream, with the potential to cause systemic infections whose outcome is typically sepsis or septic shock.
"Bacterial pneumonia" is infection of the lungs or lower respiratory tract caused by a bacterium, whether gram-positive or gram-negative.
The term "adjunctive measurement", as used in relation to procalcitonin in systemic infections, implies the use of supplementary diagnostic tools alongside primary methods. Some of these tools are referred to as surrogate markers and can assist doctors and nursing staff in the early diagnosis of conditions that may be potentially fatal for critically ill patients.
The PICO question around which this paper is organized concerns adult patients admitted to the ICU who are terminally ill. These patients almost always develop bacteremia or bacterial pneumonia, which further worsens their condition and decreases their survival rate. The purpose of the question is to determine whether adjunctive measurement of procalcitonin (PCT) levels can aid in the early diagnosis of bacteremia and bacterial pneumonia, enabling prompt and appropriate treatment that reduces mortality and morbidity.
Researchers continue to work on assessment techniques that would allow clinical professionals to make an early diagnosis of such infections. One such diagnostic criterion is the adjunctive measurement of PCT levels. This paper discusses how this method and its alternatives may help save patients' lives. It also examines statistics on the deaths of critically ill patients due to bacteremia and, after analyzing available data, reaches a conclusion about whether PCT measurement offers a clear benefit or whether the evidence remains inconclusive. The PICO question is answered at the end of the paper.
Doctors and paramedic staff are deeply concerned about ICU patients developing septic shock from opportunistic infections. Once patients develop septicemia or bacteremia, saving their lives becomes extremely difficult. This section examines why it is so important for researchers and clinicians to develop methods for the early diagnosis of pathogen invasion, in order to decrease mortality and morbidity.
Most patients admitted to the ICU are elderly and therefore have very low immunity. Furthermore, because they are in the ICU, they are receiving strong medications for serious underlying conditions, which further suppresses their immune systems. Under these circumstances, opportunistic bacteria can invade the body and cause life-threatening septicemia or bacterial pneumonia. Early-stage diagnosis is critical. Although fever and dropping blood pressure may signal developing bacteremia, these signs are not specific enough for a definitive clinical diagnosis. Hence, the development of specific methods — such as PCT level measurement — for the early detection of worsening health is essential. The next step would be to treat patients with bacterial pneumonia and bacteremia appropriately and promptly.
According to theory, automated continuous-monitoring systems allow doctors and nursing staff to detect bacterial invasion within a few hours of blood sample collection. In actual clinical practice, however, it takes at least 12 to 24 hours to obtain Gram stain results after blood is drawn. This delay is one of the main reasons patients face worse outcomes and extended ICU stays. By contrast, newer methods such as the polymerase chain reaction allow reliable and rapid identification of bacteria, but the facilities for conducting such tests are not available in most clinical centers. While clinical manifestations remain the best approach to diagnosis, recently discovered surrogate markers can offer significant assistance in identifying major human bacterial strains within the first few hours of managing bacteremic patients.
A study based on 147 patients admitted across five different ICUs found that the most common source of infection was the lower respiratory tract, affecting 32.0% of patients infected with opportunistic pathogens. Drugs tested for treating these infections included ceftazidime, imipenem, and ciprofloxacin, which were found to be the most effective against bacteria isolated from blood cultures. The independent risk factors for mortality were identified as the development of septic shock and fatal underlying conditions. Treatment with appropriate antibiotics did not prove to significantly improve survival in these patients. The findings suggested that preventing bacterial pneumonia and lower respiratory tract colonization are critical for reducing hospital-acquired gram-negative septicemia in ICU patients, and that the most significant risk factors for death are the underlying disease and septic shock (Jang et al., 1999).
Serum procalcitonin (PCT) is a peptide based on 116 amino acids. A strong association has been established between elevated PCT and systemic bacterial infections. The measurement of serum PCT relies on a fast, routine laboratory test with a documented ability to distinguish between non-infectious acute inflammatory conditions and systemic bacterial infection (Digiovine et al., 1999). By contrast, serum C-reactive protein and white blood cell count lack this discriminatory ability. Furthermore, results have shown that the magnitude of PCT elevation has a close association with outcomes in critically ill patients (Beekmann, 2003).
Some studies have also suggested that the degree of PCT elevation varies according to the underlying pathogen. This means that different magnitudes of serum PCT elevation are expected in cases of infective endocarditis, bacterial pneumonia, and bacteremia (Luzzani et al., 2003). Nonetheless, only a handful of conflicting results regarding which PCT magnitude can differentiate between gram-positive and gram-negative bacterial strains have been published when considering critically ill patients who have simultaneously developed sepsis (Opal et al., 1999). However, differences in the signaling pathways of the inflammatory response induced by the two bacterial species have been established. Since PCT elevation is considered to have an intricate relationship with the host's cytokine response to microbial challenge, it is assumed that differences in PCT values according to bacterial strain exist from the onset of bacterial manifestation (Harbarth et al., 2001).
It is indeed very important to improve survival in critically ill patients with bacterial pneumonia and bacteremia, and this is achieved by many interventions, the most important being the administration of broad-spectrum antibiotics. Recent studies have suggested that "door-to-needle" time is a crucial factor in the survival of patients who have developed sepsis. Data from clinical studies and the latest guidelines assist doctors in choosing an antibiotic for empiric treatment (Ibrahim et al., 2000). Nonetheless, some researchers believe that in 25% of cases, antibiotic treatment was changed once Gram stain results were received. Surrogate markers therefore make it possible for doctors to choose appropriate treatment more rapidly (Munson et al., 2003).
Findings of some studies have suggested that PCT elevation may be significantly higher in patients who have developed gram-negative bacteremia compared to those with gram-positive bacteremia. Furthermore, no confounding variables were identified in those studies. It should be noted that some studies involving critically ill patients with sepsis have either not addressed this issue or have not confirmed it (Muller et al., 2000). Nonetheless, some studies have suggested that in patients with S. pneumoniae manifestation, PCT was more elevated than in gram-negative bacteremia, such as in the case of Legionella, an atypical microbe (Prat et al., 2006). In patients with infective endocarditis, PCT elevation was found to be greater in cases of gram-negative bacteremia compared to gram-positive bacteremia. The reason for these contradictory results may be that in some studies, patients were infected by more than one strain or type of bacteria. Some authors have also shown that in patients with established sepsis, PCT was significantly elevated compared to patients who did not develop sepsis, making these differences more pronounced in such cases (Boussekey et al., 2005).
Since PCT is thought to be elevated in direct association with the host's immune response and the inflammatory mediators released as a defense mechanism against offending pathogens, different cytokine responses may account for the variation in PCT elevation patterns described above. The fact that gram-negative and gram-positive bacteria are known to induce inflammatory responses that depend on different patterns of innate immunity supports this hypothesis. It was suggested that the function of Toll-like receptors in the whole-blood response to different bacteria was significantly variable and relied on the composition of the outer membrane of the offending pathogens. One of the main determinants of Gram stain results is outer membrane composition, meaning that the magnitude of the cytokine response depends upon the nature of the invading bacteria. Studies have shown that tumor necrosis factor-α (TNF-α) plays a crucial role in the cytokine response to invading pathogens, though plasma levels of TNF are not necessarily elevated regardless of the causative pathogen. Since this cytokine plays a critical role in the release of PCT from different cell lines during systemic bacterial infection, it can be suggested that the magnitude of PCT elevation may be related to characteristics of the invading bacteria. Some in vitro studies have shown that the peak value of PCT was significantly higher in supernatants of human cells cultured and stimulated with lipopolysaccharide compared to those stimulated with muramyl dipeptide, a component of the outer membrane of gram-positive bacteria (Tavares et al., 2005). It was also notable that no significant difference was observed in CRP kinetics. Moreover, previous studies have shown that Candida species circulating in the bloodstream were less likely to induce elevation in serum PCT levels in critically ill patients compared to bacteria, which may also contribute to differences in immune response patterns (Charles et al., 2006).
However, the results of all studies conducted in this regard should be interpreted with caution. First, findings cannot be generalized to all patients with sepsis, since most studies included only patients who had developed bacteremia and not necessarily sepsis. Second, the positive predictive value of a PCT level below 16.0 ng/mL is quite low and cannot be reliably applied in clinical settings. Third, the mortality rate was higher in patients with gram-negative bacteremia than in those with gram-positive bacterial strains. Since the magnitude of PCT elevation is directly linked to the severity and prognosis of disease, clinicians should not overlook the fact that patients with gram-positive manifestation are probably less critically ill than those with gram-negative pathogen invasion. Although SOFA scores and admission SAPS II scores were found to be comparable in patients with gram-positive and gram-negative bacteremia, some differences in health status were noted (Garrouste-Orgeas, 2006). The possibility that patients with gram-positive bacteremia were more likely to have received immunosuppressive drugs cannot be excluded, though none of the patients in any of the studies mentioned received immunosuppressive drugs other than steroids following the onset of septic shock. Notably, an equal number of patients from both the gram-positive and gram-negative groups developed septic shock at bacteremia onset and were treated with hydrocortisone. It has also not been established whether patients with a depressed immune system tend to show lower serum PCT levels when bacterial sepsis sets in. Finally, the amount of soft tissue infections was greatly increased in patients with gram-positive manifestation. Therefore, PCT measurement and clinical diagnosis can be made earlier in these patients, and lower PCT levels could be obtained independent of Gram stain results. Nonetheless, somewhat similar results can be obtained when patients with soft tissue infections are excluded from the analysis, and a low PCT value has been shown to be consistently independently associated with gram-positive bacteremia even in settings where soft tissue is considered a source of infection.
Meisner, M., Tschaikowsky, K., Palmaers, T., & Schmidt, J. (1999). Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Critical Care, 3, 45–50.
Muller, B., Becker, K. L., Schachinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000). Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Critical Care Medicine, 28, 977–983.
Munson, E. L., Diekema, D. J., Beekmann, S. E., Chapin, K. C., & Doern, G. V. (2003). Detection and treatment of bloodstream infection: Laboratory reporting and antimicrobial management. Journal of Clinical Microbiology, 41, 495–497.
Opal, S. M., & Cohen, J. (1999). Clinical gram-positive sepsis: Does it fundamentally differ from gram-negative bacterial sepsis? Critical Care Medicine, 27, 1608–1616.
Prat, C., Dominguez, J., Andreo, F., Blanco, S., Pallares, A., Cuchillo, F., Ramil, C., Ruiz-Manzano, J., & Ausina, V. (2006). Procalcitonin and neopterin correlation with aetiology and severity of pneumonia. Journal of Infection, 52, 169–177.
Tavares, E., Maldonado, R., Ojeda, M. L., & Minano, F. J. (2005). Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats. Clinical and Diagnostic Laboratory Immunology, 12, 1085–1093.
You’re 64% through this paper. Sign up to read the remaining 3 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.